Skip to Content
CN
EN
Products
Applications
Services
Resources
Support
Analytical Chemistry
Cell Culture & Analysis
Chemistry & Biochemicals
Clinical & Diagnostics
Filtration
Greener Alternative Products
Industrial Microbiology
Lab Automation
Labware
Materials Science
Molecular Biology & Functional Genomics
mAbs Development & Manufacturing
mRNA Development & Manufacturing
Pharma & Biopharma Manufacturing
Protein Biology
Water Purification
Analytical Chemistry
Cell Culture & Analysis
Chemistry & Synthesis
Clinical & Diagnostics
Environmental & Cannabis Testing
Food & Beverage Testing & Manufacturing
Genomics
Materials Science & Engineering
Microbiological Testing
mAbs Development & Manufacturing
mRNA Development & Manufacturing
Pharma & Biopharma Manufacturing
Protein Biology
Research & Disease Areas
Water Purification
Contract Manufacturing
Contract Testing
Custom Products
Digital Solutions for Life Science
IVD Development & Manufacturing
Product Services
Support
Documents
Learning Center
New
User Guide for Millipore Website Consolidation
Web Training
Ordering Information
Customer Support
After-Sales Support
Technical Support
Process Solution Support
Contact Us
Get Site Smart
FAQ
Quality & Regulatory
Calculators & Apps
Webinars
Home
Search Results
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer.
ACS chemical biology (2018)
Terai, et al.
PMID
26390252
MATERIALS
Product Number
Brand
Product Description
SML3156
Sigma-Aldrich
ALW-II-41-27, ≥98% (HPLC)
Pricing
